Biogen's Fampyra Launched in Canada - Analyst Blog NASDAQ Besides BG-12, Biogen is developing other multiple sclerosis candidates like daclizumab, in partnership with Abbott Labs ( ABT ), and PEGylated interferon. Biogen recently signed an exclusive, worldwide option and collaboration agreement with privately ... |
